The Young Turks discuss a pro-life group’s “sting” operation at Planned Parenthood:
Sex-selective abortions are legal in Austin, Texas. The counselor explained to the woman her options available under the law. Live Action reportedly edited out the part of the video where she talked about adoption as an option.
Planned Parenthood fired the woman anyway, because it is against their policy to advocate sex-selective abortion. They then said they were “retraining” their employees. That’s what really bothers me about this story; if they failed to train their employees properly to begin with, then that is on them, not her. This woman, who seems like a thoroughly decent person, shouldn’t have her career ruined because of this stupid video. As TYT points out, it legitimizes the effectiveness of what is essentially propaganda.
I went to Planned Parenthood today. I’ve been going there for years for my pills, and this was the first time I ever actually saw a protestor with a fetus poster. He looked very lonely.
Anyway, I was on Yaz a few years ago and in addition to the lack of baby, it made my skin pregnancy-glow awesome. I quit due to costs. (It’s a relatively new drug and I’m sure has a long patent life ahead.) But today I mentioned possibly switching my pill back. The doctor said it is now Planned Parenthood’s policy to no longer prescribe Yaz due to the increased risk of embolism.
It’s time for another edition of “Candice Reads Primary Source Articles So You Don’t Have To.”
Here’s the Yaz (drospirenone) study from BMJ:
Conclusion: After adjustment for length of use, users of oral contraceptives with desogestrel, gestodene, or drospirenone were at least at twice the risk of venous thromboembolism [outlink mine] compared with users of oral contraceptives with levonorgestrel.
The study methodology looks pretty solid to me. It had a good sample size and controlled for a lot of variables. The important part to take away is the interpretation of the conclusion.
What’s the baseline risk for venous thromboembolism?
The risk, like everything, depends on your genes. The incidence of VTE* is about 1 in 1,000 each year, which, if you think about in terms of percentage, is a 0.001% rate. Men are at higher risk than women. Asian and Hisapnic women are at lower risk than Caucasian or African. High BMI is also a risk factor.
Those stats not only include men, but whatever women were on birth control. So even if you multiply that risk by seven (6-7 times more at risk than women not on birth control is what the BMJ study suggests), I still don’t think it’s clinically significant. If it was, the drug would have been pulled from pharmacy shelves a long time ago.
As a skinny, half-Asian, with no family history of VTE, I want my Yaz back.
*American Heart Association